Annual EBIT
$890.52 M
+$119.78 M+15.54%
31 March 2024
Summary:
Dr Reddys Laboratories Limited annual earnings before interest & taxes is currently $890.52 million, with the most recent change of +$119.78 million (+15.54%) on 31 March 2024. During the last 3 years, it has risen by +$522.34 million (+141.87%). RDY annual EBIT is now at all-time high.RDY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$237.83 M
0.00%
01 September 2024
Summary:
Dr Reddys Laboratories Limited quarterly earnings before interest & taxes is currently $237.83 millionOver the past year, it has increased by +$2.15 million (+0.91%). RDY quarterly EBIT is now at all-time high.RDY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$661.82 M
0.00%
01 September 2024
Summary:
Dr Reddys Laboratories Limited TTM earnings before interest & taxes is currently $661.82 millionOver the past year, it has dropped by -$158.48 million (-19.32%). RDY TTM EBIT is now -24.32% below its all-time high of $874.47 million, reached on 31 March 2024.RDY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.5% | +0.9% | -19.3% |
| 3 y3 years | +141.9% | +36.5% | +62.6% |
| 5 y5 years | +167.0% | +110.5% | +65.9% |
RDY EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +141.9% | at high | +98.0% | -24.3% | +62.6% |
| 5 y | 5 years | at high | +232.6% | at high | +431.1% | -24.3% | +172.1% |
| alltime | all time | at high | +1855.6% | at high | +226.9% | -24.3% | +453.8% |
Dr Reddys Laboratories Limited EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $237.83 M(+18.9%) | $661.82 M(-24.3%) |
| Mar 2024 | $890.52 M(+15.5%) | $200.00 M(-10.7%) | $874.47 M(+4.1%) |
| Dec 2023 | - | $224.00 M(-5.0%) | $840.15 M(+2.4%) |
| Sept 2023 | - | $235.68 M(+9.7%) | $820.30 M(+3.8%) |
| June 2023 | - | $214.80 M(+29.7%) | $790.44 M(+2.6%) |
| Mar 2023 | $770.75 M(+72.6%) | $165.68 M(-18.8%) | $770.09 M(+6.3%) |
| Dec 2022 | - | $204.15 M(-0.8%) | $724.53 M(+11.0%) |
| Sept 2022 | - | $205.82 M(+5.8%) | $652.77 M(+5.1%) |
| June 2022 | - | $194.45 M(+61.9%) | $621.25 M(+17.2%) |
| Mar 2022 | $446.43 M(+21.3%) | $120.12 M(-9.3%) | $530.11 M(+6.3%) |
| Dec 2021 | - | $132.39 M(-24.0%) | $498.54 M(+22.5%) |
| Sept 2021 | - | $174.30 M(+68.7%) | $407.13 M(+15.7%) |
| June 2021 | - | $103.30 M(+16.7%) | $351.87 M(-4.1%) |
| Mar 2021 | $368.19 M(+37.5%) | $88.55 M(+116.1%) | $366.99 M(-3.4%) |
| Dec 2020 | - | $40.98 M(-65.6%) | $379.96 M(+42.2%) |
| Sept 2020 | - | $119.04 M(+0.5%) | $267.14 M(+2.3%) |
| June 2020 | - | $118.42 M(+16.7%) | $261.08 M(-2.9%) |
| Mar 2020 | $267.76 M(-19.7%) | $101.51 M(-241.3%) | $268.91 M(+10.6%) |
| Dec 2019 | - | -$71.84 M(-163.6%) | $243.19 M(-39.0%) |
| Sept 2019 | - | $112.98 M(-10.5%) | $398.83 M(+7.4%) |
| June 2019 | - | $126.26 M(+66.6%) | $371.20 M(+17.4%) |
| Mar 2019 | $333.54 M(+42.1%) | $75.79 M(-9.6%) | $316.07 M(+12.3%) |
| Dec 2018 | - | $83.80 M(-1.8%) | $281.41 M(-3.8%) |
| Sept 2018 | - | $85.35 M(+20.0%) | $292.63 M(+8.0%) |
| June 2018 | - | $71.13 M(+72.9%) | $271.03 M(+25.9%) |
| Mar 2018 | $234.67 M(+2.9%) | $41.13 M(-56.7%) | $215.21 M(-4.2%) |
| Dec 2017 | - | $95.01 M(+49.0%) | $224.61 M(+2.1%) |
| Sept 2017 | - | $63.76 M(+316.7%) | $219.89 M(+2.1%) |
| June 2017 | - | $15.30 M(-69.7%) | $215.31 M(-5.5%) |
| Mar 2017 | $227.97 M(-46.7%) | $50.54 M(-44.0%) | $227.73 M(+5.2%) |
| Dec 2016 | - | $90.29 M(+52.6%) | $216.50 M(-11.1%) |
| Sept 2016 | - | $59.17 M(+113.4%) | $243.64 M(-25.7%) |
| June 2016 | - | $27.72 M(-29.5%) | $327.92 M(-23.8%) |
| Mar 2016 | $427.51 M(-10.7%) | $39.31 M(-66.5%) | $430.43 M(-12.4%) |
| Dec 2015 | - | $117.43 M(-18.1%) | $491.13 M(-4.0%) |
| Sept 2015 | - | $143.46 M(+10.2%) | $511.51 M(+5.0%) |
| June 2015 | - | $130.23 M(+30.2%) | $487.01 M(+1.8%) |
| Mar 2015 | $478.59 M(+3.4%) | $100.02 M(-27.4%) | $478.50 M(-0.8%) |
| Dec 2014 | - | $137.81 M(+15.9%) | $482.21 M(-1.6%) |
| Sept 2014 | - | $118.95 M(-2.3%) | $489.85 M(-2.2%) |
| June 2014 | - | $121.73 M(+17.3%) | $500.80 M(+9.4%) |
| Mar 2014 | $462.70 M(+10.8%) | $103.73 M(-28.7%) | $457.78 M(-9.2%) |
| Dec 2013 | - | $145.44 M(+12.0%) | $504.20 M(+12.4%) |
| Sept 2013 | - | $129.90 M(+65.0%) | $448.63 M(+6.4%) |
| June 2013 | - | $78.71 M(-47.6%) | $421.68 M(+1.1%) |
| Mar 2013 | $417.55 M | $150.15 M(+67.1%) | $417.27 M(+29.3%) |
| Dec 2012 | - | $89.87 M(-12.7%) | $322.62 M(-17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $102.95 M(+38.5%) | $391.42 M(+4.4%) |
| June 2012 | - | $74.31 M(+33.9%) | $375.05 M(+2.1%) |
| Mar 2012 | $409.35 M(+47.0%) | $55.49 M(-65.0%) | $367.45 M(-6.8%) |
| Dec 2011 | - | $158.67 M(+83.3%) | $394.22 M(+30.9%) |
| Sept 2011 | - | $86.58 M(+29.8%) | $301.23 M(+5.5%) |
| June 2011 | - | $66.71 M(-18.9%) | $285.41 M(+2.5%) |
| Mar 2011 | $278.42 M(+443.8%) | $82.27 M(+25.3%) | $278.54 M(+14.5%) |
| Dec 2010 | - | $65.67 M(-7.2%) | $243.29 M(+377.3%) |
| Sept 2010 | - | $70.76 M(+18.2%) | $50.98 M(+30.0%) |
| June 2010 | - | $59.85 M(+27.3%) | $39.23 M(-17.2%) |
| Mar 2010 | $51.20 M(-200.9%) | $47.02 M(-137.1%) | $47.36 M(-125.3%) |
| Dec 2009 | - | -$126.65 M(-314.6%) | -$187.09 M(-1102.2%) |
| Sept 2009 | - | $59.01 M(-13.2%) | $18.67 M(+944.3%) |
| June 2009 | - | $67.98 M(-136.3%) | $1.79 M(-105.6%) |
| Mar 2009 | -$50.72 M(-151.5%) | -$187.43 M(-336.9%) | -$31.67 M(-116.3%) |
| Dec 2008 | - | $79.11 M(+87.8%) | $193.72 M(+153.6%) |
| Sept 2008 | - | $42.13 M(+22.0%) | $76.38 M(+0.6%) |
| June 2008 | - | $34.52 M(-9.1%) | $75.96 M(-22.8%) |
| Mar 2008 | $98.42 M(-60.6%) | $37.96 M(-199.3%) | $98.45 M(-29.0%) |
| Dec 2007 | - | -$38.23 M(-191.7%) | $138.63 M(-38.1%) |
| Sept 2007 | - | $41.71 M(-26.9%) | $223.97 M(-15.7%) |
| June 2007 | - | $57.02 M(-27.0%) | $265.76 M(+6.8%) |
| Mar 2007 | $249.71 M(+662.2%) | $78.14 M(+65.9%) | $248.92 M(+50.9%) |
| Dec 2006 | - | $47.11 M(-43.6%) | $164.99 M(+22.8%) |
| Sept 2006 | - | $83.49 M(+107.8%) | $134.38 M(+102.5%) |
| June 2006 | - | $40.18 M(-794.7%) | $66.36 M(+106.1%) |
| Mar 2006 | $32.76 M(-607.4%) | -$5.78 M(-135.1%) | $32.21 M(+43.4%) |
| Dec 2005 | - | $16.49 M(+6.5%) | $22.46 M(+424.6%) |
| Sept 2005 | - | $15.48 M(+157.3%) | $4.28 M(-587.8%) |
| June 2005 | - | $6.02 M(-138.8%) | -$877.80 K(-85.2%) |
| Mar 2005 | -$6.46 M(-114.2%) | -$15.52 M(+817.4%) | -$5.92 M(-292.5%) |
| Dec 2004 | - | -$1.69 M(-116.4%) | $3.07 M(-82.4%) |
| Sept 2004 | - | $10.32 M(+954.3%) | $17.42 M(-38.0%) |
| June 2004 | - | $979.00 K(-115.0%) | $28.09 M(-37.7%) |
| Mar 2004 | $45.39 M(-34.1%) | -$6.54 M(-151.6%) | $45.06 M(-28.6%) |
| Dec 2003 | - | $12.66 M(-39.7%) | $63.08 M(-0.6%) |
| Sept 2003 | - | $20.99 M(+17.0%) | $63.48 M(+3.1%) |
| June 2003 | - | $17.95 M(+56.2%) | $61.59 M(-10.5%) |
| Mar 2003 | $68.90 M(-35.0%) | $11.49 M(-12.0%) | $68.83 M(-7.7%) |
| Dec 2002 | - | $13.05 M(-31.7%) | $74.61 M(-19.4%) |
| Sept 2002 | - | $19.10 M(-24.2%) | $92.53 M(-23.0%) |
| June 2002 | - | $25.19 M(+45.9%) | $120.18 M(+13.4%) |
| Mar 2002 | $105.94 M(+226.0%) | $17.27 M(-44.3%) | $105.95 M(+19.5%) |
| Dec 2001 | - | $30.98 M(-33.7%) | $88.69 M(+53.7%) |
| Sept 2001 | - | $46.74 M(+326.1%) | $57.71 M(+426.1%) |
| June 2001 | - | $10.97 M | $10.97 M |
| Mar 2001 | $32.49 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual earnings before interest & taxes?
- What is the all time high annual EBIT for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual EBIT year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly EBIT year-on-year change?
- What is Dr Reddys Laboratories Limited TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM EBIT year-on-year change?
What is Dr Reddys Laboratories Limited annual earnings before interest & taxes?
The current annual EBIT of RDY is $890.52 M
What is the all time high annual EBIT for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual earnings before interest & taxes is $1.07 B
What is Dr Reddys Laboratories Limited annual EBIT year-on-year change?
Over the past year, RDY annual earnings before interest & taxes has changed by +$119.78 M (+15.54%)
What is Dr Reddys Laboratories Limited quarterly earnings before interest & taxes?
The current quarterly EBIT of RDY is $237.83 M
What is the all time high quarterly EBIT for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly earnings before interest & taxes is $237.83 M
What is Dr Reddys Laboratories Limited quarterly EBIT year-on-year change?
Over the past year, RDY quarterly earnings before interest & taxes has changed by +$2.15 M (+0.91%)
What is Dr Reddys Laboratories Limited TTM earnings before interest & taxes?
The current TTM EBIT of RDY is $661.82 M
What is the all time high TTM EBIT for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM earnings before interest & taxes is $874.47 M
What is Dr Reddys Laboratories Limited TTM EBIT year-on-year change?
Over the past year, RDY TTM earnings before interest & taxes has changed by -$158.48 M (-19.32%)